William B. Messer

4.7k total citations · 1 hit paper
62 papers, 2.4k citations indexed

About

William B. Messer is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, William B. Messer has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 33 papers in Public Health, Environmental and Occupational Health and 7 papers in Epidemiology. Recurrent topics in William B. Messer's work include Mosquito-borne diseases and control (32 papers), Viral Infections and Vectors (26 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). William B. Messer is often cited by papers focused on Mosquito-borne diseases and control (32 papers), Viral Infections and Vectors (26 papers) and SARS-CoV-2 and COVID-19 Research (14 papers). William B. Messer collaborates with scholars based in United States, Puerto Rico and South Korea. William B. Messer's co-authors include Aravinda M. de Silva, Kamalanayani Sivananthan, Duane J. Gubler, Eva Harris, Fikadu Tafesse, Hans C. Leier, Ralph S. Baric, Wahala M. P. B. Wahala, Zoë L. Lyski and Vivek Shandas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.

In The Last Decade

William B. Messer

57 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants

2022 173 citations Timothy A. Bates, Savannah K. McBride et al. Science Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William B. Messer United States	21	1.8k	1.6k	208	178	169	62	2.4k
Kriengsak Limkittikul Thailand	21	1.2k 0.7×	1.7k 1.0×	130 0.6×	219 1.2×	138 0.8×	66	2.0k
Mauricio Guzmán Cuba	27	1.7k 1.0×	2.3k 1.4×	174 0.8×	174 1.0×	122 0.7×	53	2.7k
Andrew K. Falconar Colombia	24	1.6k 0.9×	2.2k 1.4×	170 0.8×	290 1.6×	224 1.3×	53	2.4k
Dieudonné Nkoghe Gabon	30	1.9k 1.0×	1.9k 1.2×	131 0.6×	495 2.8×	163 1.0×	68	3.1k
Ousmane Faye Senegal	32	2.1k 1.2×	2.1k 1.3×	176 0.8×	504 2.8×	208 1.2×	141	3.7k
Jyh-Hsiung Huang Taiwan	25	1.4k 0.8×	1.6k 1.0×	115 0.6×	212 1.2×	107 0.6×	32	2.0k
Felicity J. Burt South Africa	32	3.3k 1.9×	1.9k 1.2×	188 0.9×	430 2.4×	125 0.7×	82	4.0k
Gilberto A. Santiago United States	18	1.2k 0.7×	1.4k 0.9×	94 0.5×	214 1.2×	127 0.8×	40	1.7k
Hugues Tolou France	27	2.1k 1.2×	2.5k 1.6×	197 0.9×	257 1.4×	220 1.3×	64	2.9k
Chonticha Klungthong Thailand	25	1.5k 0.8×	1.8k 1.1×	129 0.6×	316 1.8×	167 1.0×	85	2.2k

Countries citing papers authored by William B. Messer

Since Specialization

Citations

This map shows the geographic impact of William B. Messer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William B. Messer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William B. Messer more than expected).

Fields of papers citing papers by William B. Messer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William B. Messer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William B. Messer. The network helps show where William B. Messer may publish in the future.

Co-authorship network of co-authors of William B. Messer

This figure shows the co-authorship network connecting the top 25 collaborators of William B. Messer. A scholar is included among the top collaborators of William B. Messer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William B. Messer. William B. Messer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, David X., et al.. (2025). Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19. PubMed. 2(1). 100048–100048. 1 indexed citations

Messer, William B., et al.. (2025). Endothelial leak and knowledge gaps: yellow fever virus non-structural protein 1 and the antibodies that bind it. Virology Journal. 22(1). 338–338.

Kreklywich, Craig N., Michael Denton, Luisa I. Alvarado, et al.. (2024). The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection. Vaccines. 12(8). 893–893. 16 indexed citations

Coulter, Felicity J. & William B. Messer. (2024). Breakthroughs and insights: A comprehensive review of yellow fever vaccine breakthrough infection across 8 decades. Vaccine. 43(Pt 1). 126423–126423. 2 indexed citations

Um, Jihye, William B. Messer, Yerun Zhu, et al.. (2024). Long-Term Immunity after Vaccination against Yellow Fever in Korean Travelers. Japanese Journal of Infectious Diseases. 78(2). 79–84.

Bates, Timothy A., Hans C. Leier, Savannah K. McBride, et al.. (2023). An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants. JCI Insight. 8(5). 20 indexed citations

Lyski, Zoë L., Myung Sun Kim, David X. Lee, et al.. (2022). Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia. SHILAP Revista de lepidopterología. 2022. 1–5. 2 indexed citations

Bates, Timothy A., Savannah K. McBride, Hans C. Leier, et al.. (2022). Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Science Immunology. 7(68). eabn8014–eabn8014. 173 indexed citations breakdown →

Costantini, Verónica, Kenny Nguyen, Zoë L. Lyski, et al.. (2022). Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG. The Journal of Immunology. 208(6). 1500–1508. 15 indexed citations

10.

Nickerson, Joshua P., et al.. (2022). Case Report: Yellow Fever Vaccine-Associated Neurotropic Disease and Associated MRI, EEG, and CSF Findings. Frontiers in Neurology. 12. 779014–779014. 7 indexed citations

11.

Lyski, Zoë L., Amanda E. Brunton, Sarah Siegel, et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern. The Journal of Infectious Diseases. 225(6). 947–956. 12 indexed citations

12.

Bates, Timothy A., et al.. (2021). Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2. Cell Reports. 34(7). 108737–108737. 49 indexed citations

13.

Horve, Patrick F., Leslie Dietz, Mark Fretz, et al.. (2021). Identification of SARS‐CoV‐2 RNA in healthcare heating, ventilation, and air conditioning units. Indoor Air. 31(6). 1826–1832. 33 indexed citations

14.

Lyski, Zoë L., Myung Sun Kim, David X. Lee, et al.. (2021). Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia. Blood Advances. 6(4). 1207–1211. 11 indexed citations

15.

Adam, Awadalkareem, Mary Masterson, Zoë L. Lyski, et al.. (2021). Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity. Immunology. 164(2). 386–397. 10 indexed citations

16.

Coulter, Felicity J., et al.. (2020). Potency and breadth of human primary ZIKV immune sera shows that Zika viruses cluster antigenically as a single serotype. PLoS neglected tropical diseases. 14(4). e0008006–e0008006. 7 indexed citations

17.

Horve, Patrick F., Alison Edelman, Leslie Dietz, et al.. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Environmental Contamination and Childbirth. Obstetrics and Gynecology. 136(4). 827–829. 12 indexed citations

18.

Messer, William B., Boyd L. Yount, Scott R. Royal, et al.. (2016). Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1. Journal of Virology. 90(10). 5090–5097. 26 indexed citations

19.

Shandas, Vivek & William B. Messer. (2008). Fostering Green Communities Through Civic Engagement: Community-Based Environmental Stewardship in the Portland Area. Journal of the American Planning Association. 74(4). 408–418. 91 indexed citations

20.

Messer, William B., et al.. (2008). An Anatomy of a Community-University Partnership: The Structure of Community Collaboration. Journal of higher education outreach & engagement. 12(3). 191–204. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact